Cancer patients use of nonproven therapy: a 5-year follow-up study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
T RisbergTom Wilsgaard

Abstract

To investigate the prospective pattern of use of alternative medicine, here called nonproven therapy (NPT), among oncologic patients during a 5-year period, and the relationship between this use and survival, a questionnaire-based follow-up study was performed at the Department of Oncology, University of Tromsø, from 1990 to 1996. Two-hundred fifty-two patients answered the first questionnaire during the period July 1990 to July 1991. Eligible patients were mailed follow-up questionnaires after 4, 12, 24 and 60 months. A telephone interview performed after the last follow-up questionnaire showed little disagreement with the prospective collected information as regards the number of patients reported as users of NPT (kappa, 0.92). The number of patients who reported ever using NPT in each cross-sectional part of the study varied between 17.4% and 27.3%. However, the estimated cumulative risk of being a user of NPT during the follow-up period was 45%. Seventy-four percent of NPT users in this north Norwegian study population used faith healing or healing by hand (spiritual NPT) alone or in combination with other forms of NPT. The proportion of patients who used spiritual versus nonspiritual forms of NPT was consistent throughout ...Continue Reading

Citations

Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S JacobsonF Kronenberg
Jul 9, 2002·Cancer Practice·Marja J Verhoef, Margaret A White
Jan 22, 2004·British Journal of Cancer·U WernekeD Fannon
Apr 28, 2004·Breast Cancer Research and Treatment·Yong CuiWei Zheng
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ichinosuke HyodoShigemitsu Takashima
Apr 23, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Agnete E KristoffersenVinjar M Fønnebø
Sep 1, 2016·Nanoscale Research Letters·Donghyun LeeIl Keun Kwon
Dec 28, 1999·Medical and Pediatric Oncology·J M Metz
Dec 12, 2003·Integrative Cancer Therapies·Geoffrey A Cordell
Nov 8, 2008·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Agnete Egilsdatter KristoffersenArne Johan Norheim
Dec 1, 2019·BMC Complementary and Alternative Medicine·Agnete Egilsdatter KristoffersenAnne Helen Hansen
Oct 19, 2000·Journal of Pediatric Hematology/oncology·K M KellyM A Weiner
Feb 27, 1999·Current Opinion in Obstetrics & Gynecology·C O Granai
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·P J CheethamS F Brewster
Mar 24, 2004·Integrative Cancer Therapies·Margaret A White, Marja J Verhoef
Apr 6, 2006·Palliative & Supportive Care·Zeina Nahleh, Imad A Tabbara
Oct 25, 2011·Integrative Cancer Therapies·Markus HorneberMarcel Zwahlen
Mar 12, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yi-Hsien LinJen-Hwey Chiu
Sep 17, 1998·The New England Journal of Medicine·R S DiPaolaM A Gallo
Sep 23, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Charlotte Kira KimbyHenrik Langgaard
Nov 15, 2002·Oncology Nursing Forum·Cecile A LengacherCharles E Cox
Apr 19, 2006·Journal of Psychosocial Oncology·Cleora S RobertsChris Blanchard
Mar 29, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Are GamstLaila Launsø
Jan 14, 2012·BMC Complementary and Alternative Medicine·Agnete E KristoffersenVinjar M Fønnebø
Oct 14, 2009·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Vinjar Fønnebø, Laila Launsø
Nov 26, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yi LinLei Pan
Feb 6, 2017·Journal of Cancer Survivorship : Research and Practice·Aline Sarradon-EckPatrick Peretti-Watel
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sung-Gyeong KimKui-Son Choi
Sep 23, 2009·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Agnete Egilsdatter KristoffersenArne J Norheim
Dec 31, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Danette M HannKristin Winter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
T RisbergBjarne K Jacobsen
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
T RisbergJ Norum
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
T RisbergS Kaasa
© 2021 Meta ULC. All rights reserved